Meyka Pro banner
Decarbonization Plus Acquisition Corporation

Stay Updated with the Latest Decarbonization Plus Acquisition Corporation DCRBU News in Real Time

Find DCRBU news now at Meyka AI. Stay informed with the latest Decarbonization Plus Acquisition Corporation stocks updates, including price news, market analysis, and expert insights.

DCRBUNASDAQ
Financial ServicesShell Companies
$11.15
$0.05(0.45%)
U.S. Market opens in 63h 31m
Corus Entertainment Cuts More Jobs at Global News and Radio on August 21
📅 in about 4 hours

Corus Entertainment Cuts More Jobs at Global News and Radio on August 21

Corus Entertainment confirms fresh layoffs at Global B.C., Global National, News 640, and talk radio. Q3 revenue fell 16% and the company posted a $36.5M net loss.

Read more 12
Christian Metal Band Sues Netflix Over KPop Demon Hunters Trademark, August 21
📅 9 hours ago

Christian Metal Band Sues Netflix Over KPop Demon Hunters Trademark, August 21

Christian metal band Demon Hunter sues Netflix over KPop Demon Hunters trademark infringement. Band cites consumer confusion and existential threat to 25-year-old brand.

Read more 12
Samsung Electronics Eyes $72 Billion Shareholder Return Package Amid AI Boom
📅 9 hours ago

Samsung Electronics Eyes $72 Billion Shareholder Return Package Amid AI Boom

Samsung Electronics is weighing a massive shareholder return package worth more than 100 trillion won ($72 billion) as strong AI chip demand drives record profits. On August 21, 2026, the South Korean tech giant is set to discuss the plan at a board meeting. The package could include a special dividend, share buybacks, and cancellations….

Read more 12
Gold Price Today: MCX Gold Jumps to ₹1,60,250. Why Gold Is Rising as Dollar Weakens, Fed Bets Shift
📅 9 hours ago

Gold Price Today: MCX Gold Jumps to ₹1,60,250. Why Gold Is Rising as Dollar Weakens, Fed Bets Shift

MCX gold price rose 0.52% to ₹1,60,250 on August 21, 2026, supported by a weaker dollar and falling US yields. September silver futures declined 1.02% to ₹2,45,736 on the same session. Healthy spot market demand and positive global cues drove bullion higher today. Brent crude slipped 0.27% to $93.52 a barrel, adding further support to…

Read more 12
AMD Shares Down 0.43% Despite Bullish $650 Price Target From Roth MKM
📅 10 hours ago

AMD Shares Down 0.43% Despite Bullish $650 Price Target From Roth MKM

AMD shares traded down 0.43% to $464.43 in early Thursday trading on August 20, 2026, even after Roth MKM reiterated a bullish call. The stock later reversed course, closing the session up 0.65% at $469.46. Analyst Suji Desilva maintained a Buy rating and $650 price target on the chipmaker. That target implies roughly $302 billion…

Read more 12
NVDA Stock: Nvidia Earnings Preview as Wall Street Eyes ~$92B Revenue
📅 10 hours ago

NVDA Stock: Nvidia Earnings Preview as Wall Street Eyes ~$92B Revenue

NVDA stock heads into its most important catalyst of the quarter on August 26, 2026. Nvidia reports Q2 FY27 earnings after market close, covering the period ending July 27. FactSet and LSEG consensus places revenue between $91.85 billion and $92.10 billion, just above management’s own guidance of $91.0 billion, plus or minus 2%.  That midpoint…

Read more 12
Singapore Director Declared Bankrupt Over SGD 407 Unpaid Workers Case
📅 13 hours ago

Singapore Director Declared Bankrupt Over SGD 407 Unpaid Workers Case

Ramu Palani Velu, director of KPA Engineering and six other Singapore firms, declared bankrupt after 407 migrant workers lodged claims for unpaid wages totalling months of missed salaries.

Read more 12
Australia’s H5N1 Bird Flu Crisis Deepens: 1,000+ Birds Dead Across Two States, August 21
📅 21 hours ago

Australia’s H5N1 Bird Flu Crisis Deepens: 1,000+ Birds Dead Across Two States, August 21

South Australia reports 1,000+ dead birds from suspected H5N1 flu across offshore islands. Tasmania confirms 28 dead penguins. Authorities plan vaccination programs as outbreak accelerates.

Read more 12
Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21
📅 1 day ago

Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21

Moderna stock jumps 122% after announcing its personalized mRNA melanoma vaccine met Phase 3 trial goals. The vaccine reduced cancer recurrence and spread when combined with Merck’s Keytruda.

Read more 12

DCRBU News FAQ